Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07270900 · ClinicalTrials.gov registry record · NA

A Mindfulness-based Intervention for Adolescents With Prediabetes or Type 2 Diabetes

A NA study of Type 2 Diabetes and PreDiabetes, sponsored by Indiana University.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT07270900 is a NA study of Type 2 Diabetes and PreDiabetes that has completed, run by Indiana University. The registered enrollment target is 30 participants, below the 1,103-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07270900, a NA study of Type 2 Diabetes and PreDiabetes, has completed, sponsored by Indiana University.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to conduct a mindfulness-based intervention for adolescents referred for prediabetes or type 2 diabetes treatment to 1) evaluate feasibility and acceptability of the intervention for future research and clinical use and 2) explore secondary health outcomes related to diabetes prevention and care.

Interventions

  • PROCEDURE Mindfulness Based Group

Study Locations (1)

Indiana

  • Riley Diabetes CLinic - Indianapolis

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2023-02-01
Est. Completion 2025-07-30
Phase NA

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT07270900

The ClinicalTrials.gov registry entry for NCT07270900 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,103-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (97% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Mindfulness Based Group is the first listed.

NCT07270900 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT07270900 about?

NCT07270900 is a clinical study titled "A Mindfulness-based Intervention for Adolescents With Prediabetes or Type 2 Diabetes". The purpose of this study is to conduct a mindfulness-based intervention for adolescents referred for prediabetes or type 2 diabetes treatment to 1) evaluate feasibility and acceptability of the intervention for future research and clinical use and 2) explore secondary health outcomes related to dia...

What is the current status of trial NCT07270900?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2023-02-01. Estimated completion is 2025-07-30.

What conditions does trial NCT07270900 study?

This clinical trial studies the following conditions: Type 2 Diabetes, PreDiabetes.

What interventions are being tested in trial NCT07270900?

The interventions under investigation include: Mindfulness Based Group (PROCEDURE).

Who is sponsoring clinical trial NCT07270900?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07270900 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.